We are live on
!
Find out more
GCA
Greenwood Capital Associates Portfolio holdings
AUM
$1.02B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+7.43%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$662M
AUM Growth
+$25.5M
(+4%)
Cap. Flow
-$14.8M
Cap. Flow
% of AUM
-2.24%
Top 10 Holdings %
Top 10 Hldgs %
23.91%
Holding
238
New
24
Increased
113
Reduced
64
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$7.58M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$5.69M |
| 3 |
Western Digital
WDC
|
+$3.47M |
| 4 |
iShares Global Financials ETF
IXG
|
+$3.46M |
| 5 |
Global X Silver Miners ETF NEW
SIL
|
+$3.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$6.55M |
| 2 |
Incyte
INCY
|
+$5.86M |
| 3 |
NVIDIA
NVDA
|
+$5.27M |
| 4 |
Sony
SONY
|
+$5.23M |
| 5 |
Nike
NKE
|
+$4.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.7% |
| 2 | Healthcare | 13% |
| 3 | Financials | 10.13% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 6.26% |
Similar funds
SVCP
EFM
CC
MSA
MAM
IAS
WA
GA
Greenwood Capital Associates's Q2 2021 Portfolio in Review
As of Q2 2021, Greenwood Capital Associates held 238 positions worth $662M, up 4% from $636M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Greenwood Capital Associates's Q2 2021 filing shows 24 new, 113 increased, 64 reduced and 24 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 112,353 shares worth $7.56M. The largest sale was iShares Core MSCI Total International Stock ETF, an estimated $6.55M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Greenwood Capital Associates's largest Q2 2021 buy was Vanguard FTSE Europe ETF: 112,353 shares worth $7.56M.
- Greenwood Capital Associates added most to Vertex Pharmaceuticals in Q2 2021, an estimated $5.69M increase.
- Greenwood Capital Associates's biggest Q2 2021 reduction was iShares Core MSCI Total International Stock ETF, cutting an estimated $6.55M.
- Greenwood Capital Associates fully exited Incyte in Q2 2021, selling an estimated $5.86M.
- Greenwood Capital Associates's ten largest holdings make up 24% of its $662M portfolio in Q2 2021.
- Greenwood Capital Associates opened 24 new positions and closed 24 in Q2 2021.
- Greenwood Capital Associates's portfolio value rose 4% quarter-over-quarter to $662M.
Based on Greenwood Capital Associates's 13F filing for Q2 2021, filed 16 Aug 2021.